Statistics
Publications
14
Citations
2.1K
H-Index
13
Active since
2009
Guus J.J.E. Heynen is an author at The Netherlands Cancer Institute specializing in molecular oncology, oncology, and medicine.
Publications per year
2009–2022
14
14
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun, Liqin Wang, Sidong Huang et al. · Nature · 2014 · 910 citations · Full text
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich Alexander Ruess, Guus J.J.E. Heynen, Katrin J. Ciecielski et al. · Nature Medicine · 2018 · 373 citations
Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer
Elza C. de Bruin, Catherine Cowell, Patricia H. Warne et al. · Cancer Discovery · 2014 · 209 citations · Full text
Medicine, Oncology, Pharmacology +17
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs
Anirudh Prahallad, Guus J.J.E. Heynen, Giovanni Germano et al. · Cell Reports · 2015 · 177 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 14